CareDx, Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a ge…
Medical - Diagnostics & Research
US, South San Francisco [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about CareDx, Inc's gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | - | -1.113 | - | 28 | - | -59 | - | -5 | - | -6 | - | 17 |
| 2016 | - | -0.953 | - | 40 | - | -51 | - | -7 | - | -9 | - | 23 |
| 2017 | - | -0.878 | - | 48 | - | -47 | - | -8 | - | -11 | - | 28 |
| 2018 | - | -1.313 | - | 76 | - | -70 | - | -13 | - | -17 | - | 44 |
| 2019 | - | -0.563 | - | 127 | - | -30 | - | -23 | - | -29 | - | 74 |
| 2020 | - | -0.476 | - | 189 | - | -70 | - | -40 | - | -80 | - | 111 |
| 2021 | - | -0.296 | - | 294 | - | -107 | - | -58 | - | -96 | - | 173 |
| 2022 | - | -1.431 | - | 321 | - | -76 | - | -49 | - | -65 | - | 190 |
| 2023 | - | -1.830 | - | 278 | - | -190 | - | -90 | - | -123 | - | 165 |
| 2024 | - | -0.700 | - | 329 | - | -37 | - | -50 | - | -67 | - | 195 |
| 2025 | - | -0.530 | - | 364 | - | -29 | - | -56 | - | -74 | - | 216 |
| 2026 | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F111/td> | - | 1.F111 | - | 1.F111 |
| 2027 | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F121/td> | - | 0.F121 | - | 0.F121 |